| DBV TECHNOLOGIES EO -,10 |
| Frankreich |
| Gesundheit |
| FR0010417345 / A1JWB7 |
| DBV (Frankfurt) |
| FRA:DBV, ETR:DBV, DBV:GR |
| - |
| https://dbv-technologies... |
|
DBV Technologies SA is a clinical-stage French biopharmaceutical company headquartered in Bagneux, specializing in immunotherapy for food allergies. It pioneers the Viaskin technology, an epicutaneous patch that delivers allergens like peanut or milk..
>Volltext.. |
| 731.75 Mio. EUR |
| 597.02 Mio. EUR |
| - |
| -138.54 Mio. EUR |
| -148.44 Mio. EUR |
| -0.59 EUR |
| 18.06 Mio. EUR |
| 150.45 Mio. EUR |
| -143.11 Mio. EUR |
| 3.22 |
| - |
| -34.8% |
| - |
| - |
| - |
| - |
| DBV TECHNOLOGIES, DBV TECH |
| 12.09.26 |